Dawn Svoronos

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dawn Svoronos

Earlier roles on record: Board Member at Ptc Therapeutics, Inc. (PTCT) until December 6, 2022. Ptc Therapeutics, Inc. reported in an 8-K filed December 6, 2022 that Dawn Svoronos resigned as member of the board of directors, effective December 6, 2022.

“On December 5, 2022, Dawn Svoronos, a member of the board of directors (the “Board”) of PTC Therapeutics, Inc. (the “Company”), notified the Company of her resignation from the Board effective December 6, 2022.”

Ptc Therapeutics, Inc. Form 8-K, filed December 6, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Dawn Svoronos's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Ptc Therapeutics, Inc. (PTCT)
Board Member

SEC 8-K

2022-06-08–2022-12-06
Ptc Therapeutics, Inc. (PTCT)
Proxy statement

Start not stated–2020-04-27

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Ptc Therapeutics, Inc.

PTCT

Board Member

2022-06-08–2022-12-06

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: member of the board of directors Ptc Therapeutics, Inc. (PTCT)
2022-12-06